Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Solesence (SLSN) Equity Average: 2011-2025

Historic Equity Average for Solesence (SLSN) over the last 12 years, with Sep 2025 value amounting to $17.7 million.

  • Solesence's Equity Average rose 30.72% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year increase of 30.72%. This contributed to the annual value of $8.4 million for FY2024, which is 123.12% up from last year.
  • Latest data reveals that Solesence reported Equity Average of $17.7 million as of Q3 2025, which was up 6.21% from $16.7 million recorded in Q2 2025.
  • Over the past 5 years, Solesence's Equity Average peaked at $17.7 million during Q3 2025, and registered a low of $2.9 million during Q4 2023.
  • In the last 3 years, Solesence's Equity Average had a median value of $8.4 million in 2024 and averaged $9.8 million.
  • As far as peak fluctuations go, Solesence's Equity Average tumbled by 55.36% in 2023, and later skyrocketed by 416.29% in 2024.
  • Solesence's Equity Average (Quarterly) stood at $7.6 million in 2021, then fell by 14.06% to $6.5 million in 2022, then plummeted by 55.36% to $2.9 million in 2023, then soared by 416.29% to $15.1 million in 2024, then skyrocketed by 30.72% to $17.7 million in 2025.
  • Its Equity Average stands at $17.7 million for Q3 2025, versus $16.7 million for Q2 2025 and $15.1 million for Q1 2025.